No Rx Needed for CVS/Caremark: Fool by Numbers

Recs

13

On May 8, CVS/Caremark (NYSE: CVS) released first-quarter earnings for the period ended March 31.

  • The merger between CVS and Caremark closed on March 22, so the results reflect 10 days of the consolidated company.
  • Merger and integration expenses are estimated to have shortened earnings by $25.3 million, lowering shareholder profits a penny.
  • While increasing demand for generic drugs curtailed the top line, revenue still posted an impressive 32.1% surge.
  • Front-end comparable sales rose a solid 6.6%, driven primarily by health and beauty products, digital photo services, and private label and proprietary brand sales.

(Figures in millions, except per-share data.)

Income Statement Highlights

Q1 2007

Q1 2006

Change

Sales

$13,184.6

$9,979.2

32.1%

Net Profit

$405.4

$326.1

24.3%

EPS

$0.43

$0.39

10.3%

Diluted Shares

939.8

848.5

10.8%

Get back to basics with the income statement.

Margin Checkup

Q1 2007

Q1 2006

Change*

Gross Margin

25.4%

26.6%

(1.2)

Operating Margin

5.6%

5.6%

(0.0)

Net Margin

3.1%

3.3%

(0.2)

*Expressed in percentage points.

Margins are the earnings engine.

Balance Sheet Highlights

Assets

Q1 2007

Q1 2006

Change

Cash + ST Invest.

$738.2

$387.1

90.7%

Accounts Rec.

$4,485.4

$2,015.0

122.6%

Inventory

$7,427.1

$5,704.8

30.2%

Liabilities

Q1 2007

Q1 2006

Change

Accounts Payable

$3,371.1

$2,437.6

38.3%

Long-Term Debt

$2,895.4

$1,592.2

81.8%

The balance sheet reflects the company's health.

Cash Flow Highlights

Q1 2007

Q1 2006

Change

Cash From Ops.

$707.7

$171.7

312.2%

Capital Expenditures

$311.9

$283.7

9.9%

Free Cash Flow

$395.8

($112.0)

N/A

Free cash flow is a Fool's best friend.

Related Foolishness:

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 527666, ~/articles/ArticleHandler.aspx, 7/6/2009 1:28:53 AM

Keep Reading:

“No Rx Needed for CVS/Caremark: Fool by Numbers”

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Get involved! »

Most Recent

Jul 2 at 4:22 PM

Market Summary

DJIA 8,280.74 -223.32 -2.63%
S&P 500 896.42 -26.91 -2.91%
NASD 1,796.52 +0.00 +0.00%
Sponsored by:

Related Tickers

CVS Caremark Corp

CAPS Rating 4/5 Stars

$31.07

-0.68 (-2.14%)

Outperform1417

Underperform60

Rate This Stock